Introduction
============

*Mycoplasma pneumoniae* causes primary atypical pneumonia, tracheobronchitis, pharyngitis, and asthma in humans ([@B17]; [@B31]; [@B64]). The age distribution of patients with pneumonia caused by *M. pneumoniae* is characteristic. The incidence is highest among school-aged children and young adults and lower in infants and geriatrics ([@B12]; [@B15]). Some pathogenic factors of *M. pneumoniae*, such as hydrogen peroxide, Community-Acquired Respiratory Distress Syndrome (CARDS) toxin, and nuclease, have been reported to be associated with the development of pneumonia ([@B58]; [@B11]; [@B26]; [@B18]; [@B57]). However, these pathogenic factors are insufficient to explain the age distribution of patients with pneumonia caused by *M. pneumoniae*. Generally, the immune system in infants and geriatrics is immature compared with that in young adults. The symptoms of pneumonia caused by *M. pneumoniae* are correlated with the induction of pro-inflammatory cytokines ([@B63]; [@B49]). These findings suggest that the excessive immune responses induced by *M. pneumoniae* play an important role in the development of pneumonia. In this review, the molecular mechanisms of inflammation induced by *M. pneumoniae* are summarized (**Table [1](#T1){ref-type="table"}**).

###### 

Summary of the inflammation-inducing factors of *Mycoplasma pneumoniae.*

  Gene ID   Original function                     Function in inflammation
  --------- ------------------------------------- -------------------------------------
  MPN602    F~0~F~1~ ATP synthase subunit b       Diacylated lipoprotein
  MPN052    \*Hypothetical                        4\*Triacylated lipoprotein
  MPN162                                          
  MPN415                                          
  MPN611                                          
  MPN141    Cytadherence, P1 adhesin              Pro-inflammatory cytokine induction
  MPN142    Cytadherence, P40, P90                5\*Activation of inflammasome
  MPN453    Cytadherence, P30                     
  MPN447    Cytadherence, HMW1                    
  MPN372    ADP-ribosylating toxin, CARDS toxin   
  MPN333    ABC transporter                       Autophagy/TLR4 dependent
  MPN597    F~0~F~1~ ATP synthase subunit ε       inflammation

Lipoproteins and Toll-Like Receptors (TLRs)
===========================================

Lipoproteins of *Mycoplasma* Species
------------------------------------

It has been reported that some *Mycoplasma* species induce pro-inflammatory cytokines and stimulate various immune cells ([@B3]; [@B29]; [@B62]). Because *Mycoplasma* species are devoid of a cell wall and lack immune cell stimulator such as lipopolysaccharide (LPS) or peptidoglycan ([@B43]; [@B59]), the factors responsible for the induction of inflammatory responses have been unclear for a long time. The first report on the inflammation-inducing factor of *Mycoplasma* species was published by [@B48]. They reported that a high-molecular-weight (HMW) protein of *M. fermentans* known as MDHM possesses interleukin (IL)-6-inducing activity in macrophages. Because the activity of MDHM was resistant to proteinase K, the active component of MDHM was thought to be a low-molecular-weight compound. In 1996, Muhlradt et al. identified the active component of MDHM as *S*-(2,3-dihydroxypropyl) cysteine ([@B46]). This component was similar to the N-terminal structure of an *Escherichia coli*-derived lipoprotein identified in 1969 by Braun et al. [@B8]. [@B44] also purified the inflammation-inducing factor from *M. fermentans* culture and demonstrated that the active component is the diacylated lipopeptide, *S*-(2,3-bisacyloxypropyl)-CGNNDESNISFKEK. They named it macrophage-activating lipopeptide-2 (MALP-2). After these reports, inflammation-inducing lipoproteins were purified and identified in various *Mycoplasma* species ([@B22]; [@B44], [@B45]; [@B52]), including *M. pneumoniae* ([@B53]).

Structure of Lipoprotein and TLR
--------------------------------

Lipoproteins were discovered in 1969 by Braun et al. ([@B8]). Lipoproteins are hydrophilic membrane proteins characterized by a conserved N-terminal lipid-modified cysteine residue. Lipoproteins contain *S*-glyceryl cysteine modified with three fatty acids (*N*-acyl-*S*-diacylglyceryl cysteine) at their N-terminal. This triacylated structure is also called Braun's lipoprotein. Braun's Lipoproteins are synthesized by the following three steps (**Figure [1](#F1){ref-type="fig"}**): (1) Transfer of the diacylglyceryl moiety from a membrane phospholipid to a cysteine residue of a protein through the recognition of the lipobox (L-\[A/S/T\]-\[G/A\]-C) by prolipoprotein diacylglyceryl transferase (Lgt); (2) Digestion of the signal sequence at the amino-terminal side of the cysteine by prolipoprotein signal peptidase (Lsp); and (3) Linkage of an acyl chain to the amino group of the amino-terminal cysteine (*N*-acylation) by prolipoprotein *N*-acyl-transferase (Lnt). Because genes orthologous to Lnt gene are not found in some bacterial species (Firmicutes and and Tenericutes), including *Mycoplasma* species, lipoproteins from these bacterial species have been assumed to be of the diacylated form ([@B47]).

![**Biosynthesis of bacterial lipoproteins. (1)** Lgt transfers a diacylglyceryl moiety from a phospholipid to the sulfhydryl group of the cysteine located after the lipobox sequence. **(2)** Lsp cleaves the signal peptide at the N-terminus of the cysteine. **(3)** Lnt transfers an acyl chain derived from phospholipid to the amino group of the cysteine.](fmicb-07-00414-g001){#F1}

Toll-like receptors are a type of pattern-recognition receptors that play critical roles in early innate recognition and host inflammatory responses against invading microbes ([@B30]; [@B1]). Among the 11 reported TLR family members, TLR2 plays a central role in the recognition of lipoproteins. TLR2 recognizes the *S*-diacylglyceryl cysteine portions of both diacylated and triacylated lipoproteins ([@B6]). TLR1 coordinate with TLR2 to recognize triacylated lipoproteins through the recognition of the third acyl chain amide-linked to the cysteine using a hydrophobic pocket within TLR1 ([@B24]). However, TLR2 alone is not able to recognize diacylated lipoproteins. TLR6 assists in the recognition of diacylated lipoproteins by associating with the amino acid portion of diacylated lipoproteins ([@B25]). Although there are some exceptions ([@B9]; [@B33]), diacylated and triacylated lipoproteins are generally recognaized by TLR2/6 and TLR2/1 heterodimers, respectively.

The presence of triacylated lipoproteins in *Mycoplasma* species has been controversial. The lipoproteins from *M. fermentans*, *M. hyorhinis*, *M. salivarium*, and *M. gallisepticum* have been shown to be diacylated lipoproteins and not *N*-acylated ([@B22]; [@B44], [@B45]; [@B52]). The Lnt gene, which encodes the enzyme responsible for N-acylation has not been found in any mycoplasma genomes ([@B16]; [@B19]; [@B50]). However, a study on the ratio of *N*-amide and *O*-ester bonds in *M. gallisepticum* and *M. mycoides* suggested the presence of triacylated lipoproteins ([@B23]). Furthermore, the resistance to Edoman degradation of proteins from *M. mycoides* also indicated the presence of *N*-acylation ([@B10]). These data imply the presence of triacylated lipoproteins in *Mycoplasma* species.

Lipoproteins of *M. pneumoniae*
-------------------------------

Lipoproteins of *M. pneumonie* are summarized in **Table [2](#T2){ref-type="table"}**. In *M. pneumoniae*, [@B53] reported that the subunit b of the F~0~F~1~ ATP synthase (MPN602) is a diacylated lipoprotein that induces inflammatory responses through TLR2. [@B21] also reported that *M. pneumoniae* has 48 lipoproteins and that the common N-terminal structure of these lipoproteins induces inflammatory responses. Interestingly, Some of these lipoproteins (MPN162, MPN611) were recognized by TLR1 and TLR2, suggesting that *M. pneumoniae* contains triacylted lipoproteins ([@B54]). [@B34] analyzed the detailed structure of *M. pneumoniae* lipoproteins using lipoprotein lipase-based mass spectrometry analysis, and demonstrated that some of *M. pneumoniae* lipoproteins (MPN052, MPN415) are triacylated. In this study, triacylated lipoproteins were also found in *M. genitalium*. These findings led to the conclusion that *Mycoplasma* species possess triacylated lipoproteins and indicated that a new enzyme with Lnt activity exists in *Mycoplasma* species. Although the modification of other 43 lipoproteins of *M. penoumoniae* is still unclear, the lipoproteins of *M. pneumoniae* seem mixture of diacylated and triacylated lipoproteins. Induction of inflammatory responses through both TLR2/6 and TLR2/1 by diacylated and triacylated lipoproteins may affect the strong inflammation in *M. pneumoniae* infection.

###### 

Summary of lipoproteins of *M. pneumoniae.*

  Gene ID   Gene symbol   Original function                                     Usage of TLR   Number of acyl chain
  --------- ------------- ----------------------------------------------------- -------------- ----------------------
  MPN011                  Hypothetical                                                         
  MPN052                  Hypothetical                                                         3^a^
  MPN054                  Hypothetical                                                         
  MPN058                  Hypothetical                                                         
  MPN083                  Hypothetical                                                         
  MPN097                  Pseudo                                                               
  MPN133                  Hypothetical                                                         
  MPN152                  Hypothetical                                                         
  MPN162                  Hypothetical                                          1, 2           3^b^
  MPN199                  Hypothetical                                                         
  MPN200                  Hypothetical                                                         
  MPN271                  Hypothetical                                                         
  MPN281                  Pseudo                                                               
  MPN284                  Hypothetical                                                         
  MPN288                  Hypothetical                                                         
  MPN363                  Hypothetical                                                         
  MPN369                  Hypothetical                                                         
  MPN408                  Hypothetical                                                         
  MPN411                  Hypothetical                                                         
  MPN415                  High affinity transport system protein P37                           3^a^
  MPN436                  Hypothetical                                                         
  MPN439                  Pseudo                                                               
  MPN442                  Hypothetical                                                         
  MPN456                  Hypothetical                                                         
  MPN459                  Hypothetical                                                         
  MPN467                  Hypothetical                                                         
  MPN489                  Hypothetical                                                         
  MPN506                  Hypothetical                                                         
  MPN523                  Hypothetical                                                         
  MPN582                  Hypothetical                                                         
  MPN585                  Hypothetical                                                         
  MPN587                  Hypothetical                                                         
  MPN588                  Hypothetical                                                         
  MPN590                  Hypothetical                                                         
  MPN592                  Hypothetical                                                         
  MPN602    atpF          F~0~F~1~ ATP synthase subunit b                       2, 6           2^b^
  MPN611                  Phosphate ABC transporter substrate-binding protein   1, 2           3^b^
  MPN639                  Hypothetical                                                         
  MPN640                  Hypothetical                                                         
  MPN641                  Hypothetical                                                         
  MPN642                  Hypothetical                                                         
  MPN643                  Hypothetical                                                         
  MPN644                  Hypothetical                                                         
  MPN645                  Hypothetical                                                         
  MPN646                  Hypothetical                                                         
  MPN647                  Hypothetical                                                         
  MPN650                  Hypothetical                                                         
  MPN654                  Hypothetical                                                         

a

Determined by lipase-based mass spectrometry analysis.

b

Estimated from TLR usage.

TLR2-Independent Inflammation
=============================

*M. pneumoniae* and Autophagy
-----------------------------

Because *Mycoplasma* species lack cell walls, they do not contain immunostimulants such as LPS, peptidoglycan, or lipoteichoic acid. Therefore, lipoproteins seem to be key factors in *M. pneumoniae*-induced inflammatory responses and to facilitate the development of pneumonia in humans. However, the existence of lipoproteins in non-pathogenic *Mycoplasma* species suggests the presence of an alternative mechanism by which *M. pneumoniae* induce inflammatory responses.

Autophagy is a cellular response that involves the sequestration of regions within the cytosol with double membrane compartments. Autophagy has been shown to play important roles in the cellular response to starvation, cell death, removal of damaged organelles, and neurodegenerative diseases ([@B35]). It has recently been recognized that autophagy is involved in both innate and adaptive immunity against various microorganisms ([@B51]; [@B13]; [@B36]).

Recently, Shimizu et al. demonstrated that *M. pneumoniae* induces strong inflammatory responses, even in macrophages derived from TLR2 knockout (KO) mice ([@B56]). *M. pneumoniae* internalized into macrophages through phagocytosis were co-localized with the autophagosome, and autophagy inhibitors decreased the induction of pro-inflammatory cytokines, suggesting the autophagy-mediated induction of inflammatory responses. Because this TLR2-independent induction was inhibited in macrophages derived from TLR2/4 double KO mouse, TLR4 is also involved. In this study, they also reported that the ABC-transporter (MPN333), and F~0~F~1~ ATP synthase subunit ε (MPN597) of *M. pneumoniae* are essential for the activation of the autophagy/TLR4-mediated pathway.

*M. pneumoniae* and the Inflammasome
------------------------------------

Inflammasomes are intracellular receptors ([@B39]), that respond to various signals, including intracellular bacterial toxins, pathogen-associated molecular patterns (PAMPs) ([@B38]; [@B40]), damage-associated molecular patterns (DAMPs) ([@B28]; [@B37]; [@B61]), and reactive oxygen species ([@B14]; [@B2]). Activated inflammasomes cleave the precursors of pro-inflammatory cytokines, such as IL-1β and IL-18 through caspase-1 or caspase-11, and release them ([@B7]).

[@B55] reported that *M. pneumoniae* induces eﬄux of ATP from host cells. The eﬄux of ATP activated inflammasomes via the P2X7 receptor, which is followed by the secretion of IL-1β. A recent report by [@B60] also demonstrated that *M. pnumoniae* induces IL-1β through the NLRP3 inflammasome in a dendritic cell line.

Interestingly, [@B5] showed that CARDS toxin (MPN372) regulates NLRP3 inflammasome activity. CARDs toxin is a vacuolating cytotoxin produced by some *Mycoplasma* species, including *M. pneumoniae*. Its C-terminal region is responsible for its vacuolating activity ([@B26]; [@B27]). Its N-terminal region shares sequence similarity with pertussis toxin and is essential for its ADP-ribosylating activity. In this study, they demonstrated that CARDS toxin activates inflammasomes through the ADP-ribosylation of NLRP3 and enhances the secretion of IL-1β.

Taken together, these findings suggest that inflammasomes play an important role in the inflammation induced by *M. pneumoniae*.

Cytadherence of *M. pneumoniae* and Inflammation
------------------------------------------------

Cytadherence property is one of the unique characteristics of *M. pneumoniae.* Cytadherence in the respiratory tract, the initial event in *M. pneumoniae* infection, is mediated by P1 (MPN141) adhesin and other accessory proteins, such as P30 and HMW proteins ([@B32]; [@B4]; [@B41],[@B42]). The relationship between cytoadherence and the induction of inflammatory responses was first reported in [@B65]. They demonstrated that protease treatment or anti-P1 antibody treatment decreases the induction of pro-inflammatory cytokines, including IL-1β. [@B20] reported that culturing *M. pneumoniae* in polypropylene bottles reduces the expression of P1 adhesin. Under these conditions, the induction of IL-4 from mast cells was significantly decreased. As described above, Shimizu et al. reported that *M. pneumoniae* induces the eﬄux of ATP from host cells, followed by the activation of inflammasomes and secretion of IL-1β. In this study, they also reported that cytadherence-deficient mutants lacking P90 and P40 (MPN142, 130 kDa precursor) or HMW1 and P30 (MPN447 and MPN453, respectively) fail to induce IL-1β through ATP eﬄux. Cytadherence was also associated with autophagy/TLR4-mediated induction of inflammatory responses. Mutation in ABC-transporter (MPN333), and F~0~F~1~ ATP synthase subunit ε (MPN597) failed to induce inflammatory responses, and these mutants showed a deficiency in cytadherence ([@B56]). Taken together, these findings indicate that cytadherence of *M. pneumoniae* is strongly associated with the induction of inflammatory responses.

Conclusion
==========

In this review, the molecular mechanisms of inflammatory responses induced by *M. pneumoniae* were reviewed (**Figure [2](#F2){ref-type="fig"}**). The following four pathways are important for the induction of inflammatory responses in *M. pneumoniae* infection: 1) recognition of lipoprotein by TLR2, 2) autophagy-mediated signaling; 3) activation of inflammasomes, and 4) cytadherence property. Lipoproteins, which were the first immunostimulants discovered in *Mycoplasma* species, have been well studied. However, the structures of the lipoproteins in *Mycoplasma* species are identical to those of lipoproteins from other bacteria, including normal microflora. Therefore, lipoproteins alone are insufficient to explain the inflammatory responses induced by *M. pneumoniae*. *M. pneumoniae* also has the ability to induce inflammatory responses through a TLR2-independent pathway. Autophagy and TLR4 are involved in this induction. Some pro-inflammatory cytokines, such as IL-1β and IL-18, are matured and released through inflammasome activation. Inflammasome activation is necessary to release these cytokines during *M. pneumoniae* infection. It is noteworthy that CARDS toxin enhances inflammasome activation. The distribution of CARDS toxin in *Mycoplasma* species is limited to a small number of *Mycoplasma* species. In addition, cytadherent property of *M. pneumoniae* is strongly associated with the autophagy/TLR4- and inflammasome- mediated induction of inflammatory responses. Although some *Mycoplasma* species, such as *M. genitalium* and *M. gallisepticum*, have partially similar adhesin, cytadherence mediated by P1 adhesin is unique in *M. pneumoniae*. These characteristics may contribute to the greater ability of *M. pneumoniae* to induce inflammatory responses than non-pathogenic *Mycoplasma* species.

![**Summary of the inflammation-inducing pathways in *Mycoplasma pneumoniae* infection.** The following four pathways are involved in the induction of inflammatory responses: **(1)** recognition of lipoprotein by TLR2, **(2)** autophagy-mediated signaling, **(3)** activation of inflammasomes, and **(4)** cytadherence property.](fmicb-07-00414-g002){#F2}

In addition to inflammation-inducing factors, *M. pneumoniae* shows cytotoxicity through CARDS toxin, nuclease, and hydrogen peroxide produced during glycerol metabolism. The symptoms of mycoplasmal pneumonia, such as fever and severe cough, are thought to appear as a result of a combination of inflammation and cytotoxicity induced by *M. pneumoniae*. Mycoplasmal pneumonia is still an important issue in the field of pediatric medicine. Although measures to prevent mycoplasmal pneumonia are desired worldwide, preventive measures, including vaccines, have not been developed. Therefore, the inflammation-inducing factors of *M. pneumoniae* described here may be suitable targets for the development of new preventive measures.
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